Ruby Benjamin-Garner1, Angela Stotts. 1. Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Ruby.A.Benjamin-Garner@uth.tmc.edu
Abstract
INTRODUCTION: Despite the known harmful effects of smoking during pregnancy, the highly addicted find it difficult to quit. Decreased smoking may be regarded as a means of harm reduction. There is limited information on the benefits of smoking reduction short of quitting. This study used salivary cotinine to assess the impact of change in smoking exposure on birth weight in full-term infants. METHODS: In a prenatal smoking cessation study, smoking status was validated by saliva cotinine at baseline and end of pregnancy (EOP). Salivary cotinine ≥15 ng/ml defined active smoking. Based on salivary cotinine, women were grouped as nonsmoking/quit, light exposure (<150 ng/ml), and heavy exposure (≥150 ng/ml) at baseline and EOP. EOP and baseline smoking status were stratified to form smoking exposure change groups. Mean birth weight was compared among those who quit, reduced, maintained, and increased. RESULTS:Smoking cessation was associated with a 299 g increase in birth weight compared with sustained heavy smoking, p = .021. Reduced exposure from heavy to light was associated with a 199 g increase in birth weight compared with sustained heavy exposure, a 103 g increase compared with increased exposure, and a 63 g increase compared with sustained light exposure. Differences among continuing smokers were not statistically significant. CONCLUSIONS: Although not statistically significant, the increase in infant birth weight associated with reduction from heavy to light exposure suggests potential for benefit. The only statistically significant comparison was between quitters and sustained heavy smokers, confirming that smoking cessation should remain the goal for pregnant women.
RCT Entities:
INTRODUCTION: Despite the known harmful effects of smoking during pregnancy, the highly addicted find it difficult to quit. Decreased smoking may be regarded as a means of harm reduction. There is limited information on the benefits of smoking reduction short of quitting. This study used salivary cotinine to assess the impact of change in smoking exposure on birth weight in full-term infants. METHODS: In a prenatal smoking cessation study, smoking status was validated by saliva cotinine at baseline and end of pregnancy (EOP). Salivary cotinine ≥15 ng/ml defined active smoking. Based on salivary cotinine, women were grouped as nonsmoking/quit, light exposure (<150 ng/ml), and heavy exposure (≥150 ng/ml) at baseline and EOP. EOP and baseline smoking status were stratified to form smoking exposure change groups. Mean birth weight was compared among those who quit, reduced, maintained, and increased. RESULTS: Smoking cessation was associated with a 299 g increase in birth weight compared with sustained heavy smoking, p = .021. Reduced exposure from heavy to light was associated with a 199 g increase in birth weight compared with sustained heavy exposure, a 103 g increase compared with increased exposure, and a 63 g increase compared with sustained light exposure. Differences among continuing smokers were not statistically significant. CONCLUSIONS: Although not statistically significant, the increase in infant birth weight associated with reduction from heavy to light exposure suggests potential for benefit. The only statistically significant comparison was between quitters and sustained heavy smokers, confirming that smoking cessation should remain the goal for pregnant women.
Authors: Kristine Marceau; L Cinnamon Bidwell; Hollis C Karoly; Allison Schettini Evans; Alexandre A Todorov; Rohan H Palmer; Andrew C Heath; Valerie S Knopik Journal: J Abnorm Child Psychol Date: 2018-05
Authors: Stephen T Higgins; Tyler D Nighbor; Allison N Kurti; Sarah H Heil; Eric P Slade; Donald S Shepard; Laura J Solomon; Mary Ellen Lynch; Harley K Johnson; Catherine Markesich; Peter L Rippberger; Joan M Skelly; Michael DeSarno; Janice Bunn; Jessie B Hammond; Maria L Roemhildt; Rhonda K Williams; Deirdre M O'Reilly; Ira M Bernstein Journal: Prev Med Date: 2022-03-03 Impact factor: 4.637
Authors: Valerie S Knopik; Kristine Marceau; Rohan H C Palmer; Taylor F Smith; Andrew C Heath Journal: Behav Genet Date: 2015-10-22 Impact factor: 2.805
Authors: Valerie S Knopik; Andrew C Heath; Kristine Marceau; Rohan H C Palmer; John E McGeary; Alexandre Todorov; Allison Schettini Evans Journal: Twin Res Hum Genet Date: 2015-07-29 Impact factor: 1.587
Authors: Oluwatosin Olaiya; Andrea J Sharma; Van T Tong; Deborah Dee; Celia Quinn; Israel T Agaku; Elizabeth J Conrey; Nicole M Kuiper; Glen A Satten Journal: Prev Med Date: 2015-10-31 Impact factor: 4.018
Authors: Asthildur Erlingsdottir; Emil L Sigurdsson; Jon Steinar Jonsson; Hildur Kristjansdottir; Johann A Sigurdsson Journal: Scand J Prim Health Care Date: 2014-02-17 Impact factor: 2.581